Skip to main content
Kyowa Kirin Co.,Ltd. logo

Kyowa Kirin Co.,Ltd. — Investor Relations & Filings

Ticker · 4151 ISIN · JP3256000005 LEI · 529900TBXKVTQGYA3582 T Manufacturing
Open in API
Filings indexed 75 across all filing types
Latest filing 2024-11-14 Transaction in Own Shar…
Country JP Japan
Listing T 4151

About Kyowa Kirin Co.,Ltd.

https://www.kyowakirin.com/index.html

Kyowa Kirin is a global specialty pharmaceutical company engaged in the research, development, manufacturing, and commercialization of innovative medicines. Leveraging advanced biotechnology and expertise in antibody engineering, the company is dedicated to addressing unmet medical needs. Its primary focus is on creating novel treatments in therapeutic areas such as oncology, nephrology, and immunology. Kyowa Kirin is committed to discovering and delivering drugs for complex and rare diseases, aiming to improve the health and well-being of patients worldwide.

Recent filings

Filing Released Lang Actions
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares
2024-11-14 Japanese
臨時報告書
Board/Management Information Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and is submitted to the Kanto Local Finance Bureau Director. Section 1 explicitly states the reason for filing: a resolution regarding the change in representative directors made at the Board of Directors meeting on October 31, 2024, pursuant to Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act. This document details the names, new/old positions, effective dates (scheduled for the March 2025 AGM), and shareholdings of the outgoing and incoming representative directors, including a change in the CEO/President role. This content directly relates to changes in senior management/board structure. The most fitting category is Board/Management Information (MANG), as it specifically covers changes in the company's senior management (representative directors). It is not a full Annual Report (10-K), an Earnings Release (ER), or a general regulatory filing (RNS), as MANG is more specific to this content.
2024-10-31 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is titled "自己株券買付状況報告書（法24条の６第１項に基づくもの）" which translates to "Report on the Status of Treasury Stock Acquisition (Based on Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act)". This filing explicitly details the company's (Kyowa Kirin Co., Ltd.) transactions involving the purchase of its own shares during a specific reporting period (September 1 to September 30, 2024). This directly corresponds to the definition of a report detailing the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). The document is a detailed report, not an announcement of a report, and the content is highly specific to share repurchases.
2024-10-11 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is titled "自己株券買付状況報告書" (Report on the Status of Treasury Stock Acquisition) and explicitly cites the legal basis as "金融商品取引法第24条の６第１項" (Financial Instruments and Exchange Act Article 24-6, Paragraph 1). This type of filing in Japan details the monthly progress of a company's share repurchase program, including the number of shares acquired during the reporting period (August 1 to August 31, 2024) and the cumulative total. This directly corresponds to reporting on the company's own share transactions, which is classified as 'Transaction in Own Shares' (POS). The document is a detailed report, not an announcement of a report, and the content is highly specific to share repurchases.
2024-09-12 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is titled "自己株券買付状況報告書（法24条の６第１項に基づくもの）" which translates to "Report on the Status of Treasury Stock Acquisition (Based on Article 24-6, Paragraph 1)". This is a specific regulatory filing in Japan detailing the company's share repurchase activities during a defined period (July 1 to July 31, 2024). This content directly relates to the company buying back or selling its own shares, which corresponds to the definition of 'Transaction in Own Shares' (POS). It is not a general earnings release (ER), an annual report (10-K), or a mere announcement of a report (RPA), but the actual report detailing the transaction status.
2024-08-09 Japanese
半期報告書－第102期(2024/01/01－2024/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '第２四半期報告書' (Second Quarter Report) for Kyowa Kirin Co., Ltd., covering the period from January 1, 2024, to June 30, 2024. It contains detailed financial statements, management analysis (MDA), and operational data, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2024
2024-08-01 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.